Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 11;4(3):e001544.
doi: 10.1161/JAHA.114.001544.

Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community

Bernhard M Kaess  1 , Sarah R Preis  2 , Wolfgang Lieb  3 , Alexa S Beiser  4 , Qiong Yang  2 , Tai C Chen  5 , Christian Hengstenberg  6 , Jeanette Erdmann  7 , Heribert Schunkert  6 , Sudha Seshadri  8 , Ramachandran S Vasan  9 ; CARDIoGRAM; Themistocles L Assimes, Panos Deloukas, Hilma Holm, Sekar Kathiresan, Inke R König, Ruth McPherson, Muredach P Reilly, Robert Roberts, Nilesh J Samani, Alexandre F R Stewart
Collaborators, Affiliations

Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community

Bernhard M Kaess et al. J Am Heart Assoc. .

Erratum in

Abstract

Background: Brain-derived neurotrophic factor (BDNF) is a pleiotropic peptide involved in maintaining endothelial integrity. It is unknown if circulating BDNF levels are associated with risk of cardiovascular disease (CVD).

Methods and results: We prospectively investigated the association of circulating BDNF levels with cardiovascular events and mortality in 3687 participants (mean age 65 years, 2068 women) from the Framingham Heart Study (FHS). Using a common nonsynonomous single nucleotide polymorphism (SNP) in the BDNF gene (rs6265), we then performed a Mendelian randomization experiment in the CARDIoGRAM (Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis) consortium (>22,000 coronary artery disease [CAD] cases, >60,000 controls) to investigate whether SNP rs6265 was associated with CAD in CARDIoGRAM and, if so, whether the effect estimate differed from that predicted based on FHS data. On follow-up (median 8.9 years), 467 individuals (261 women) in FHS experienced a CVD event, and 835 (430 women) died. In multivariable-adjusted Cox regression, serum BDNF was associated inversely with CVD risk (hazard ratio [HR] per 1-SD increase 0.88, 95% CI 0.80 to 0.97, P=0.01) and with mortality (HR 0.87, 95% CI 0.80 to 0.93, P=0.0002). SNP rs6265 was associated with BDNF concentrations (0.772 ng/mL increase per minor allele copy) in FHS. In CARDIoGRAM, SNP rs6265 was associated with CAD (odds ratio 0.957, 95% CI 0.923 to 0.992), a magnitude consistent with the predicted effect (HR per minor allele copy 0.99, 95% CI 0.98 to 1.0; P=0.06 for difference between predicted and observed effect).

Conclusion: Higher serum BDNF is associated with a decreased risk of CVD and mortality. Mendelian randomization suggests a causal protective role of BDNF in the pathogenesis of CVD.

Keywords: Mendelian randomization; cardiovascular disease; growth factors; mortality; risk factors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Age‐ and sex‐adjusted cumulative incidence of cardiovascular events (top panel) and all‐cause mortality (bottom panel), stratified by quartiles of serum BDNF. BDNF indicates brain‐derived neurotrophic factor; CVD, cardiovascular disease.
Figure 2.
Figure 2.
Relations of serum BDNF with cardiovascular events (top panel) and all‐cause mortality (bottom panel)—multivariable adjusted spline regression. BDNF indicates brain‐derived neurotrophic factor; CVD, cardiovascular disease.
Figure 3.
Figure 3.
Mendelian randomization experiment. BDNF indicates brain‐derived neurotrophic factor; CAD, coronary artery disease; CVD, cardiovascular disease; HR, hazard ratio.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Caporali A, Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev. 2009; 89:279-308. - PMC - PubMed
    1. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 2000; 19:1290-1300. - PMC - PubMed
    1. Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, Wang S, Ibanez CF, Rafii S, Hempstead BL. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development. 2000; 127:4531-4540. - PubMed
    1. Okada S, Yokoyama M, Toko H, Tateno K, Moriya J, Shimizu I, Nojima A, Ito T, Yoshida Y, Kobayashi Y, Katagiri H, Minamino T, Komuro I. Brain‐derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system‐mediated pathway. Arterioscler Thromb Vasc Biol. 2012; 32:1902-1909. - PubMed
    1. Jiang H, Liu Y, Zhang Y, Chen ZY. Association of plasma brain‐derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris. Biochem Biophys Res Commun. 2011; 415:99-103. - PubMed

Publication types

MeSH terms

LinkOut - more resources